2012 annual financial data
ImmuCell 2012 Operating cash flow margin
Direct answer
Operating cash flow margin was 6.39%.
Operating income was 245,000 USD and net income was 89,512 USD.
Operating cash flow was 344,390 USD.
Get free ImmuCell email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 5,389,935 USD
- Operating income
- 245,000 USD
- Net income
- 89,512 USD
- Operating cash flow
- 344,390 USD